PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency and Acute Medicine, Campus Mitte and Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'German Centre for Infection Research (DZIF), Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Labor Berlin - Charité Vivantes GmbH, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Institute for Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Medical Directorate, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Emergency and Acute Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Pediatrics, Division of Pulmonology Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/1354750X.2021.1876769
?:doi
?:hasPublicationType
?:journal
  • Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
is ?:pmid of
?:pmid
?:pmid
  • 33455451
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all